High-affinity recombinant rabbits with a focus on drug discovery also produce monoclonal antibodies.
Kyoto Pharmaceutical Industry Co., Ltd. offers antibody services from the American company Abwiz Bio. 【Features of Monoclonal Antibody Production】 ■ Using Abwiz Bio's proprietary antibody gene cloning method, WizAmpTM (patented in the United States), we can produce antibodies with high specificity and high affinity. ■ By combining a vector specialized for rabbit antibody expression with WizAmpTM, known as RabWizTM, we have successfully obtained numerous antibody clones that were difficult to acquire using traditional phage vectors.
Inquire About This Product
basic information
【Examples of Past Successes】 - Antibodies against phosphorylated, methylated, and glycosylated proteins - Antibodies against low molecular weight compounds (such as hormones) - Virus strain-specific antibodies (SARS-CoV-2 vs. SARS-CoV) - Creation of idiotype antibodies - Creation of antibodies against G protein-coupled receptors (GPCRs) For more details, please visit our website (https://www.kyokutoseiyaku.co.jp/products/antibody/service/custom/).
Price range
Delivery Time
Applications/Examples of results
[Examples of Success So Far] - Antibodies against phosphorylated, methylated, and glycosylated proteins - Antibodies against low molecular weight compounds (such as hormones) - Virus strain-specific antibodies (SARS-CoV-2 vs. SARS-CoV) - Creation of idiotype antibodies - Creation of antibodies against G protein-coupled receptors (GPCRs)
catalog(4)
Download All CatalogsNews about this product(1)
Company information
Since its founding, Kyokuto Pharmaceutical Industrial has supported the medical field in protecting human "health" through the manufacture and sale of bacterial culture media, media and reagents for bacterial testing, and clinical testing reagents and equipment. Looking to the future, we are now adding the perspective of "preventive medicine testing" to our traditional focus on "diagnostic and therapeutic testing." Based on the technologies and know-how accumulated in clinical testing, we are also venturing into the fields of cell culture-related products that serve as raw materials for advanced medicine and pharmaceuticals, as well as food and environmental testing, embarking on new challenges.